https://www.marketscreener.com/quote/stock/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Pharmaceutical-Investigational-Subcutaneous-Vedolizumab-Achieves-and-Maintains-Clinical-Rem-27460104/?utm_source=telegram&utm_medium=social&utm_campaign=share